Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Like Small Cap Stocks < $20?
You should, we just banked a 30% winner in 2 days!
...
Health Technology » Pharmaceuticals Major
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| PFE | Pfizer Inc. | 3.51% | 52.43 | 0.9% | $1363.76m | |
| JNJ | Johnson & Johnson | 1.74% | 176.97 | 0.7% | $1352.49m | |
| BMY | Bristol-Myers Squibb Co. | 0.36% | 76.23 | 1.0% | $1197.90m | |
| ABBV | AbbVie, Inc. | -0.53% | 150.92 | 1.9% | $1137.44m | |
| MRK | Merck & Co., Inc. | 1.26% | 93.25 | 0.7% | $1136.00m | |
| LLY | Eli Lilly & Co. | 4.49% | 299.11 | 1.1% | $892.99m | |
| AZN | AstraZeneca Plc | 2.59% | 66.21 | 1.0% | $517.65m | |
| BHVN | Biohaven Pharmaceutical Holding Co. Ltd. | 0.65% | 141.96 | 0.0% | $458.27m | |
| VERU | Veru, Inc. | -6.37% | 13.38 | 0.0% | $318.66m | |
| NVS | Novartis AG | 0.86% | 89.41 | 0.2% | $251.17m | |
| GSK | GlaxoSmithKline Plc | 2.23% | 44.53 | 0.2% | $243.21m | |
| HZNP | Horizon Therapeutics Plc | 1.13% | 90.35 | 5.4% | $200.40m | |
| NVO | Novo Nordisk A/S | 3.49% | 107.68 | 0.1% | $190.60m | |
| SGEN | Seagen Inc. | -2.10% | 139.64 | 5.7% | $181.75m | |
| VTRS | Viatris, Inc. | 0.94% | 11.80 | 0.0% | $166.13m |
Company Profile
Horizon Therapeutics Plc is a biopharmaceutical company, which is engaged in the research, development, and marketing of pharmaceutical products. It operates through the Orphan and Inflammation segments. The Orphan segment consists of medicines KRYSTEXXA, RAVICTI, PROCYSBI, ACTIMMUNE, BUPHENYL, QUINSAIR, and RAYOS. The Inflammation segment comprises medicines PENNSAID 2%, DUEXIS, and VIMOVO. The company was founded in 2008 and is headquartered in Dublin, Ireland.